维普中文期刊产品整合服务
64篇 您的检索式:作者名="Mutnick"
    题名 作者 年代 出处 被引量
1Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America ( 1999-2001 ) 显示文摘Mutnick AH Rhomberg PR Sader HS 2004J Antimicrob Chemother2004,53,2:1
2Antimicrobial activity of LB10827,a new orally administered cephalosporin,tested against Haemophilus influenzae,Moraxella catarrhalis,and Streptococcus pneumoniae显示文摘Deshpande L M Beach M L Mutnick A H 2003Clin Microbiol Infect2003,9,8:1
3Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America(1999 ~ 2001)显示文摘Mutnick All Rhomberg PR Sader HS et al 2004Journal of Antimicrobial Chemotherapy2004,53,:1
4Antimierobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001)显示文摘Mutnick AH Rhomberg PR Sader HS 2004J Antimicrob Chemother2004,53,2:1
5Linezolidresistance since 2001:SENTRY Antimicrobial SurveillanceProgram显示文摘Mutnick Alan H Enne Victoria Jones Ronald N 2003The Annals pharmacotherapy2003,37,6:1
6Antimicrobial usage and resistance trend relationships from the MYSTIC programme in North America(1999-2001)显示文摘Mutnick AH Rhomberg PR Sader HS 2004J Antimicrob Chemother2004,53,2:1
7Evidence for modulation of smooth muscle force by the p38 MAP kinase/HSP27 pathway显示文摘Yamboliev I A Hedges J C Mutnick J L 2000Am J Physiol Heart Circ Physiol2000,278,6:1
8Antimicrobial activity of LB10827,a new orally administered cephalosporin,tested against Haemophilus influenzae,Moraxella catarrhalis and Streptococcus pneumoniae显示文摘Deshpande LM Beach ML Mutnick AH 2003Clin Microbiol Infect2003,9,8:1
9Geographic variations in garenoxacin(BMS284756)activity tested against pathogens associated with skin and soft tissue infections:report from the SENTRY Antimicrobial Surveillance Program(2000)显示文摘Kirby J T Mutnick A H Jones R N 2002Diagn Microbiol Infect Dis2002,439,4:1
10Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program(2000)显示文摘Kirby JT Mutnick AH Jones RN 2002Diagn Microbiol Infect Dis2002,439,4:1
11Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimierobial Surveillance Program (2000) 显示文摘Kirby JT Mutnick AH Jones RN 2002Diagn Microbiol Infect Dis2002,439,4:1
12Using multiple pharmacoeconomic methods to conduct a cost-effectiveness analysis of histamine H2- receptor antagonists 显示文摘McCoy S Blayney-Chandramouli J Mutnick A 1998Am J Health-Syst Pharm1998,55,4:1
13PBL and beyond: trends in collaborative learning 显示文摘Pluta WJ Richards BF Mutnick A 2013Teach Learn Med2013,25,1:1
14Antimicrobialusage and resistatace trend relationships from the MYSTIC Programme in North America (1999-2001)显示文摘Mutnick A H Rhomberg P R Sader H S 2004J Antimicrob Chemother2004,53,2:1
15Linezolid resistance since 2001: Sentry antimicrobial surveillance program 显示文摘Mutnick AH Enne V Jones RN 2003Ann Pharmacother2003,37,6:1
16In vitro evaluation of BAL9141,a novel parenteral cephalosporin active against oxacillin-resistant staphylococci显示文摘JONES RN DESHPANDE LM MUTNICK AH 2002J Antimicrob Chemother2002,50,6:1
17Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000)显示文摘 Mutnick AH Jones RN 2002Diagn Microbiol Infect Dis2002,43,4:1
18Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections:report from the SENTRY Antimicrobial Surveillance Program(United States and Canada,2000)显示文摘Rennie R P Jones R N Mutnick A H 2003Diagn Microbiol Infect Dis2003,45,4:1
19Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999 - 2001)显示文摘Mutnick AH Rhomberg PR Sader HS 2004J Antimicrob Chemother2004,53,2:1
20Pharmacist- versus physician-obtainedmedication histories 显示文摘Reeder TA Mutnick A 2008Am J Health Syst Pharm2008,65,9:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费